Cipla arm Medispray Goa facility classified as VAI by USFDA Ruchika Sharma18 April 2025 3:05 PM ISTMumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the manufacturing...
Cipla gets USFDA nod for Paclitaxel Protein bound Particles for Injectable Suspension Ruchika Sharma11 April 2025 11:30 AM ISTMumbai: Cipla has announced that the Company has received final approval from the United States Food and Drug Administration (USFDA) for the ...
Cipla gets exclusive rights to market ophthalmic drug across 11 countries Ruchika Sharma20 March 2025 1:30 PM ISTAPP13007 is a novel, patent protected and USFDA approved ophthalmic product.
USFDA issues 2 observations for Cipla arm Mahape facility Ruchika Sharma21 Feb 2025 1:30 PM ISTMumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs Administration...
Cipla bags USFDA nod for chronic myeloid leukemia drug Nilotinib Ruchika Sharma21 Feb 2025 11:30 AM ISTMumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug...
Cipla completes investment of ZAR 900 million in South Africa subsidiary Ruchika Sharma19 Feb 2025 4:56 PM ISTMumbai: Cipla Limited has announced that the Company has completed an investment of approx. ZAR 900 million in Cipla Medpro South Africa...
Cipla gets VAI status for Virgonagar facility Ruchika Sharma8 Feb 2025 1:30 PM ISTMumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the Company’s manufacturing...
Cipla to invest ZAR 900 million in equity share capital of South Africa subsidiary Ruchika Sharma4 Feb 2025 12:30 PM ISTMumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary...
Cipla Global Chief Manufacturing Officer Rajeev Kumar Sinha resigns Ruchika Sharma24 Jan 2025 11:30 AM ISTMumbai: Cipla has announced that Rajeev Kumar Sinha, Global Chief Manufacturing Officer and Senior Management Personnel of the Company has...
Cipla Goa facility gets one USFDA observation Ruchika Sharma21 Jan 2025 11:30 AM ISTMumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the manufacturing...
Cipla hit with over Rs 9 crore GST penalty, plans appeal Ruchika Sharma18 Jan 2025 3:20 PM ISTDrug major Cipla has been hit with a penalty of Rs 9.77 crore by the GST Authority for alleged tax violations under the Central Goods and Services Tax...
Cipla slapped over Rs 1 crore fine by GST Authority Farhat Nasim21 Dec 2024 3:15 PM ISTCipla has expressed its disagreement with the penalty, stating that it believes the order is arbitrary and unjustified.
